Organization

Field Name

ID

Required

KCR

Scope Regional LN (STORE) (FordsRegLNSurg)

50110

yes

NAACCR

RX Summ--Scope Reg LN Sur

1292

yes


Field Length: 1

Record the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event.

Code

Label

Description

0

None

No regional lymph node surgery. No lymph nodes found in the pathologic specimen. Diagnosed at autopsy

1

Biopsy or aspiration of regional lymph node, NOS

Biopsy or aspiration of regional lymph node(s) regardless of the extent of involvement of disease.

2

Sentinel lymph node biospy

Biopsy of the first lymph node or nodes that drain a defined area of tissue within the body. Sentinel node(s) are identified by the injection of a dye or radio label at the site of the primary tumor.

3

Number of regional nodes removed unknown or not stated; regional lymph nodes removed, NOS

Sampling or dissection of regional lymph node(s) and the number of nodes removed is unknown or not states. The procedure is not specified as sentinel nodes node biopsy.

4

1-3 regional lymph nodes removed

Sampling or dissection of regional lymph node(s) with fewer than four lymph nodes found in the specimen. The procedure is not specified as sentinel node biopsy.

5

4 or more regional lymph nodes removed

Sampling or dissection of regional lymph nodes with at least four lymph nodes found in the specimen. The procedure is not specified as sentinel node biopsy.

6

Sentinel node biopsy and code 3, 4, or 5, at same time, or timing not stated

Code 2 was performed in a single surgical event with code 3, 4, or 5. Or, code 2 and 3, 4, or 5 were performed, but timing was not stated in patient record.

7

Sentinel node biopsy and code 3, 4, or 5 at different times

Code 2 was followed in a subsequent surgical event by procedures coded 3, 4, or 5.

9

 Unknown or not applicable 

 It is unknown whether regional lymph node surgery was performed; death certificate-only; for lymphomas with a lymph node primary site; an unknown or ill-defined primary; or for hematopoietic, reticuloendothelial, immunoproliferative, or myeloproliferative disease.